tiprankstipranks
BioMarin Pharmaceutical (BMRN)
NASDAQ:BMRN
US Market

BioMarin Pharmaceutical (BMRN) Income Statement

Compare
2,043 Followers

BioMarin Pharmaceutical Income Statement

Last quarter (Q3 2024), BioMarin Pharmaceutical's total revenue was $745.74M, an increase of 27.27% from the same quarter last year. In Q3, BioMarin Pharmaceutical's net income was $106.08M. See BioMarin Pharmaceutical’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 2.42B$ 2.10B$ 1.85B$ 1.86B$ 1.70B
Gross Profit
$ 1.84B$ 1.61B$ 1.38B$ 1.34B$ 1.34B
Operating Expenses
$ 1.75B$ 1.57B$ 1.46B$ 1.43B$ 1.47B
Depreciation and Amortization
$ 104.39M$ 101.97M$ 108.04M$ 105.88M$ 105.30M
EBITDA
$ 310.28M$ 267.51M$ 48.03M$ -5.85M$ 33.95M
Operating Income
$ 194.44M$ 57.55M$ -60.01M$ -96.26M$ -125.46M
Other Income/Expenses
$ -5.88M$ 14.00K$ -15.34M$ -5.56M$ 5.65M
Pretax Income
$ 188.56M$ 149.58M$ -75.35M$ -42.32M$ -94.81M
Net Income
$ 167.65M$ 141.56M$ -64.08M$ 854.03M$ -23.85M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ 0.89$ 0.76$ -0.35$ 4.75$ -0.13
Diluted EPS
$ 0.87$ 0.75$ -0.35$ 4.53$ -0.13
Weighted Average Shares Outstanding
187.83M 185.27M 182.85M 180.80M 179.04M
Weighted Average Shares Outstanding (Diluted)
191.59M 188.96M 182.85M 191.68M 179.04M
Currency in USD

BioMarin Pharmaceutical Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis